Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R44HL140735
- Recipient
-
Orpro Therapeutics Inc. UEI DMFYKL5PQLF3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,724,117
Award facts
- Assistance listing
- 93.838 Lung Diseases Research
- Completion date
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,499,635 | |
| Original award | $224,482 |
Quick answers
Who received award R44HL140735?
R44HL140735 was awarded to Orpro Therapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on January 18, 2018.
How much is award R44HL140735 worth?
$1,724,117 has been obligated on R44HL140735.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award